What's new with common genetic skin disorders?

Area of Science:

• Genetics
• Dermatology
• Pediatrics

Background:

• Common genetic disorders including neurofibromatosis type I (NF1), tuberous sclerosis, basal cell nevus syndrome (BCNS), incontinentia pigmenti, and X-linked ichthyosis present with distinct cutaneous features.
• Pediatric cases often lack a prior diagnosis, necessitating improved awareness of diagnostic signs.

Purpose of the Study:

• To review updated information on diagnostic signs for common genetic skin disorders in children.
• To highlight advancements in the care and management of affected pediatric patients.

Main Methods:

• Literature review focusing on recent findings in genetic disorder diagnosis and treatment.
• Analysis of diagnostic criteria refinement and expanded phenotypic presentations.
• Evaluation of emerging targeted therapies and genetic diagnostic technologies.

Main Results:

• Disruptions in regulatory pathways underlie disorders like BCNS, NF1, and tuberous sclerosis, leading to targeted therapies (e.g., vismodegib, rapamycin).
• Diagnostic criteria for tuberous sclerosis and incontinentia pigmenti have been refined.
• The phenotype of X-linked ichthyosis has been expanded, and preimplantation genetic diagnosis is available for NF1 and incontinentia pigmenti.

Conclusions:

• Early identification of specific skin findings (e.g., nevus anemicus, juvenile xanthogranuloma) can facilitate early NF1 diagnosis.
• Rapamycin shows promise for noninvasive treatment of skin lesions in pediatric tuberous sclerosis.
• Genetic counseling regarding reproductive options like preimplantation genetic diagnosis is crucial for affected families.